Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-avte
/
Aerovate Therapeutics Inc
AVTE
Add to Watchlist
2.680
USD
0.000
0.00%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
After-hours 07/02, 17:00 (ET)
77.68M
Market Cap
Loss
P/E TTM
Aerovate Therapeutics Inc
2.680
0.000
0.00%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
Other
56.59%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
Other
56.59%
Shareholder Types
Shareholders
Proportion
Investment Advisor
35.36%
Hedge Fund
24.74%
Venture Capital
20.09%
Investment Advisor/Hedge Fund
20.04%
Individual Investor
1.12%
Private Equity
1.08%
Research Firm
0.32%
Bank and Trust
0.14%
Insurance Company
0.02%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
241
50.10M
101.53%
+6.17M
2025Q4
225
39.61M
80.33%
+327.27K
2025Q3
217
31.51M
96.73%
+18.51M
2025Q2
214
13.42M
41.64%
+12.20M
2025Q1
214
927.53K
47.43%
-347.78K
2024Q4
217
30.84M
106.81%
-7.10M
2024Q3
214
28.32M
98.10%
-8.69M
2024Q2
210
27.84M
96.65%
-3.71M
2024Q1
181
29.16M
104.58%
-1.74M
2023Q4
173
28.88M
104.29%
-1.94M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
6.77M
13.73%
+1.98M
+41.35%
Dec 31, 2025
Fairmount Funds Management LLC
4.55M
9.23%
--
--
Dec 31, 2025
RA Capital Management, LP
3.67M
7.44%
+456.11K
+14.19%
Dec 31, 2025
VR Adviser, LLC
3.22M
6.53%
--
--
Dec 31, 2025
Bellevue Asset Management AG
3.34M
6.77%
+3.34M
--
Dec 31, 2025
Janus Henderson Investors
3.06M
6.21%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.60M
5.26%
+634.54K
+32.35%
Dec 31, 2025
Baker Bros. Advisors LP
1.64M
3.33%
+1.64M
--
Dec 31, 2025
Remedium Capital Partners, LLC
1.58M
3.2%
+1.58M
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
ProShares Hedge Replication ETF
0.02%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
ALPS Medical Breakthroughs ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
View more
iShares Micro-Cap ETF
Proportion
0.06%
iShares Russell 2000 Value ETF
Proportion
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion
0.02%
ProShares Hedge Replication ETF
Proportion
0.02%
Proshares Ultra Russell 2000
Proportion
0.01%
Global X Russell 2000 ETF
Proportion
0.01%
iShares Russell 2000 ETF
Proportion
0.01%
ProShares UltraPro Russell2000
Proportion
0.01%
ALPS Medical Breakthroughs ETF
Proportion
0%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0%